Prospective clinical trials to investigate clinical and molecular biomarkers.

about

Prospective clinical trials to investigate clinical and molecular biomarkers.

Item

http://www.wikidata.org/entity/Q38694561

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Prospective clinical trials to investigate clinical and molecular biomarkers.

@en

type

Item

label

Prospective clinical trials to investigate clinical and molecular biomarkers.

@en

prefLabel

Prospective clinical trials to investigate clinical and molecular biomarkers.

@en

P1476

Prospective clinical trials to investigate clinical and molecular biomarkers

@en

P2093

Lauren Walker

http://www.w3.org/2001/XMLSchema#string

Mario Tombini

http://www.w3.org/2001/XMLSchema#string

William Gallentine

http://www.w3.org/2001/XMLSchema#string

P2860

HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4

The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial

Oxidative stress-mediated HMGB1 biology

Specific pattern of maturation and differentiation in the formation of cortical tubers in tuberous sclerosis omplex (TSC): evidence from layer-specific marker expression

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

A genome-wide association study and biological pathway analysis of epilepsy prognosis in a prospective cohort of newly treated epilepsy

Epilepsy biomarkers.

Hippocampal sclerosis after febrile status epilepticus: the FEBSTAT study.

The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis.

Prognostic factors for time to treatment failure and time to 12 months of remission for patients with focal epilepsy: post-hoc, subgroup analyses of data from the SANAD trial.

P304

20-26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/EPI.13782

http://www.w3.org/2001/XMLSchema#string

P478

58 Suppl 3

http://www.w3.org/2001/XMLSchema#string

P50

Stéphane Auvin

Sergiusz Jóźwiak

G J Sills

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28675556

http://www.w3.org/2001/XMLSchema#string

P921

biomarker